New pain block may cut opioid use after fibroid surgery
NCT ID NCT04272086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two types of pain-relief injections (liposomal bupivacaine vs. standard bupivacaine) given during open fibroid surgery. 140 women participated to see which method reduced the need for opioid painkillers after the operation. The goal was to improve pain control and recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROID UTERUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common cholesterol drug shrink uterine fibroids?
- Could a common muscle relaxant cut narcotic use after hysterectomy?
- Study reveals hidden risks of fibroid surgery
- Can a breast cancer drug shrink fibroids? new trial aims to find out
- Numbing shots before fibroid surgery may ease Post-Op pain
- Scientists unravel the mystery of menstrual cramps and pain relief